Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8270988rdf:typepubmed:Citationlld:pubmed
pubmed-article:8270988lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C1518419lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C0015133lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C0206034lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C0086960lld:lifeskim
pubmed-article:8270988lifeskim:mentionsumls-concept:C1561491lld:lifeskim
pubmed-article:8270988pubmed:issue1lld:pubmed
pubmed-article:8270988pubmed:dateCreated1994-1-31lld:pubmed
pubmed-article:8270988pubmed:abstractTextThe combination of etoposide (E) and cisplatin (P) is an accepted standard therapy for small-cell lung cancer (SCLC); however, the optimal sequencing and administration schedule has not been defined. This study was designed to evaluate different sequencing and administration schedules of E and P in the treatment of SCLC.lld:pubmed
pubmed-article:8270988pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8270988pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8270988pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8270988pubmed:languageenglld:pubmed
pubmed-article:8270988pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8270988pubmed:citationSubsetIMlld:pubmed
pubmed-article:8270988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8270988pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8270988pubmed:statusMEDLINElld:pubmed
pubmed-article:8270988pubmed:monthJanlld:pubmed
pubmed-article:8270988pubmed:issn0732-183Xlld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:KardinalC GCGlld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:EarllJ MJMlld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:WiesenfeldMMlld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:JettJ RJRlld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:MaksymiukA...lld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:LIJ ZJZlld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:MailliardJ...lld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:VeederM HMHlld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:KrookJ EJElld:pubmed
pubmed-article:8270988pubmed:authorpubmed-author:DiegertF AFAlld:pubmed
pubmed-article:8270988pubmed:issnTypePrintlld:pubmed
pubmed-article:8270988pubmed:volume12lld:pubmed
pubmed-article:8270988pubmed:ownerNLMlld:pubmed
pubmed-article:8270988pubmed:authorsCompleteNlld:pubmed
pubmed-article:8270988pubmed:pagination70-6lld:pubmed
pubmed-article:8270988pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:meshHeadingpubmed-meshheading:8270988-...lld:pubmed
pubmed-article:8270988pubmed:year1994lld:pubmed
pubmed-article:8270988pubmed:articleTitleSequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.lld:pubmed
pubmed-article:8270988pubmed:affiliationSaskatchewan Cancer Foundation-Saskatoon Cancer Centre, Canada.lld:pubmed
pubmed-article:8270988pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8270988pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8270988pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8270988pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8270988pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:8270988pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8270988lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8270988lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8270988lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8270988lld:pubmed